Detalles de la búsqueda
1.
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
Oncologist
; 2024 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401173
2.
Baseline extracellular vesicle TGF-ß is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
Cancer
; 129(4): 521-530, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484171
3.
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
Oncologist
; 27(6): 476-486, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35298662
4.
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers.
BMC Cancer
; 21(1): 441, 2021 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882890
5.
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Lancet Oncol
; 21(12): 1589-1601, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125909
6.
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Cancer
; 126(14): 3219-3228, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32365229
7.
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.
Oncologist
; 24(9): 1149-e807, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152080
8.
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Lancet Oncol
; 19(1): 101-114, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29169877
9.
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
JAMA
; 319(18): 1880-1888, 2018 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801011
10.
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.
Int J Cancer
; 136(8): 1856-62, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25219358
11.
Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results.
Int J Clin Oncol
; 20(3): 518-24, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25091263
12.
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).
Cancer
; 120(15): 2343-51, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24752945
13.
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
Lancet Oncol
; 14(9): 893-900, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23871417
14.
Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside.
Health Aff Sch
; 2(5): qxae039, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783890
15.
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer.
Cancers (Basel)
; 16(5)2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473302
16.
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers.
Front Oncol
; 14: 1328512, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444675
17.
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.
Invest New Drugs
; 31(6): 1587-91, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24013936
18.
Predictive Capability of PD-L1 Protein Expression for Patients With Advanced NSCLC: Any Differences Based on Histology?
Clin Lung Cancer
; 24(5): 401-406, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208221
19.
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review.
Vaccines (Basel)
; 11(5)2023 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243073
20.
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
Clin Cancer Res
; 29(18): 3641-3649, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37233987